ABLi Therapeutics, Inc.
CIK 2104142 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ABLi Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jan 13, 2026 | D | 0002104142-26-000001 |
CIK 2104142 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ABLi Therapeutics, Inc..
| Filed | Form | Accession number |
|---|---|---|
| Jan 13, 2026 | D | 0002104142-26-000001 |